SEARCH

SEARCH BY CITATION

References

  • 1
    Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 114.
  • 2
    Grisham MB. Reactive metabolites of oxygen and nitrogen in biology and medicine. Austin: RG Landes Co., 1992.
  • 3
    Nappi AJ, Vass E. Hydroxyl radical formation via iron-mediated Fenton Chemistry is inhibited by methylated catechols. Biochim Biophys Acta 1998; 1425: 15967.
  • 4
    Maddipati KR, Marnett LJ. Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase. J Biol Chem 1987; 262: 17398403.
  • 5
    Lloyd RV, Hanna PM, Mason RP. The origin of the hydroxyl radical oxygen in the Fenton reaction. Free Rad Biol Med 1997; 22: 8858.
  • 6
    Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Rad Biol Med 1995; 18: 32136.
  • 7
    Ward JF, Evans JW, Limoli CL, Calabro-Jones PM. Radiation and hydrogen peroxide induced free radical damage to DNA. Br J Cancer 1987; 55: 10512.
  • 8
    Mates JM, Gomez CP, Blanca M. Chemical and biological activity of free radical scavengers in allergic diseases. Clin Chim Acta 2000; 296: 115.
  • 9
    Arouma OI. Free radicals and food. Chem Br 1993; 29: 2104.
  • 10
    Linn S. DNA damage by iron and hydrogen peroxide in vitro and in vivo. Drug Metab Rev 1998; 30: 31326.
  • 11
    Ha HC, Sirisoma NS, Kuppusamy P, Zweier JL, Woster PM, Casero RA. The natural polyamine spermine functions directly as a free radical scavenger. Proc Natl Acad Sci USA 1998; 95: 111405.
  • 12
    Halliwell B, Vitamin C. poison, prophylactic or panacea? Trends Biochem Sci 1999; 24: 2559.
  • 13
    Melov S, Schneider JA, Day BJ et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 1998; 18: 15963.
  • 14
    Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995; 270: 2969.
  • 15
    Kaouass M, Deloyer P, Gouders I, Peulen O, Dandrifosse G. Role of interleukin-1 beta, interleukin-6 and TNF-alpha in intestinal maturation induced by dietary spermine in rats. Endocrine 1997; 6: 18794.
  • 16
    Kagaya K, Miyakawa Y, Watanabe K, Fukazawa Y. Antigenic role of stress-induced catalase of Salmonella typhimurium in cell mediated immunity. Infect Immun 1992; 60: 18205.
  • 17
    Tsai KJ, Hung IJ, Chow CK, Stern A, Chao SS, Chin DTY. Impared production of nitric oxide, superoxide and hydrogen peroxide in glucose 6-phosphate dehydrogenase-deficient granulocytes. FEBS Lett 1998; 436: 4114.
  • 18
    Chen C, Zhou J, Xu H, Jiang Y, Zhu G. Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model. Biol Trace Elem Res 1997; 59: 18793.
  • 19
    Galan P, Preziosi P, Monget AL. Effects of trace elements and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long hospitalized subjects. Int J Vit Nutr Res 1997; 67: 45060.
  • 20
    DeWaart FG, Portengen L, Doekes G, Verwaal CJ, Kok FJ. Effect of 3 months vitamin E supplementation on indices of the cellular and humoral immune response in elderly subjects. Br J Nutr 1997; 78: 7614.
  • 21
    Chen F, Lu Y, Demers LM et al. Role of hydroxyl radical in silica-induced NF-kappa B activation in macrophages. Ann Clin Lab Sci 1998; 28: 113.
  • 22
    Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998; 68: 44763.
  • 23
    PithonCuri TC, DeMelo MP, Palanch AC, Miyasaka CK, Curi R. Percentage of phagocytosis, production of O2·, H2O2 and NO and antioxidant enzyme activities of rat neutrophils in culture. Cell Biochem Funct 1998; 16: 439.
  • 24
    Levinson SS. Humoral mechanisms in autoimmune disease. J Clin Immunoassay 1994; 17: 7284.
  • 25
    Lundberg I, Hedfors E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. J Rheumatol 1991; 18: 15119.
  • 26
    Fritzler MJ, Ali R, Tan EM. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix. J Immunol 1984; 132: 121622.
  • 27
    Rokeach L, Hoch SO. B-cell epitopes of Sm autoantigens. Mol Biol Rep 1992; 16: 16574.
  • 28
    Reichlin M, Harley JB. Antibodies to Ro (SSA) and the heterogeneity of systemic lupus erythematosus. J Rheumatol 1987; 14: 1127.
  • 29
    Dixit K, Ali R. Antigen binding characteristics of antibodies induced against nitric oxide modified plasmid DNA. Biochim Biophys Acta 2001; 1528: 18.
  • 30
    Islam N, Ali R. Immunological studies on DNA-lysine photoadduct. Biochem Mol Biol Int 1998; 45: 45364.
  • 31
    Tasneem S, Ali R. Binding of SLE autoantibodies to native poly(I), ROS-poly(I) and native DNA. A comparative study. J Autoimmunity 2001; 17: 199205.
  • 32
    Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993; 362: 70915.
  • 33
    Alam K, Ali R. Human anti-DNA autoantibodies and induced antibodies against ROS-modified DNA show similar antigen binding characteristics. Biochem Mol Biol Int 1999; 47: 88190.
  • 34
    Ara J, Ali R. Polynucleotide specificity of anti-ROS DNA antibodies. Clin Exp Immunol 1993; 94: 1349.
  • 35
    Naparstek Y. The role of autoantibodies in autoimmune disease. Annu Rev Immunol 1993; 11: 79104.
  • 36
    Imlay JA, Linn S. DNA damage and oxygen radical toxicity. Science 1988; 240: 13029.
  • 37
    Lunec J, Herbert K, Blount S, Griffiths HR, Emery P. 8-hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett 1994; 348: 1318.
  • 38
    Bashir S, Harris G, Denman M, Blake DR, Winyard PG. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993; 52: 65966.
  • 39
    Ashok BT, Ali R. Binding of human anti-DNA autoantibodies to reactive oxygen species modified DNA and probing oxidative DNA damage in cancer using monoclonal antibody. Int J Can 1998; 78: 4049.
  • 40
    Joenje H. Genetic toxicology of oxygen. Mutat Res 1989; 219: 193208.
  • 41
    Stich HF, Anders F. The involvement of reactive oxygen species in oral cancers of betel quid/tobacco chewers. Mutat Res 1989; 214: 4761.
  • 42
    Meneghini R. Genotoxicity of active oxygen species in mammalian cells. Mutat Res 1988; 195: 21530.
  • 43
    Ashok BT, Ali R. The aging paradox: free radical theory of aging. Exp Gerontol 1999; 34: 293303.
  • 44
    Ames BN. Endogenous oxidative DNA damage, aging and cancer. Free Rad Res Commun 1989; 7: 1218.
  • 45
    Marx JL. Oxygen free radicals linked to many diseases. Science 1987; 235: 52931.
  • 46
    Halliwell B, Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett 1987; 213: 914.
  • 47
    Naparstek Y, Madaio MP. Are DNA antibodies actually pathogenic? Lupus 1997; 6: 3079.
  • 48
    Allan IM, Vaughan ATM, Milner AE, Lunec J, Bacon PA. Structural damage to the lymphocyte nuclei by H2O2 or gamma irradiation is dependent on the mechanism of ·OH radical production. Br J Cancer 1988; 58: 347.
  • 49
    Lunec J, Griffiths HR, Blake DR. Oxygen free radicals in inflammation. ISI Atlas Sci 1987; 1: 4558.
  • 50
    Stollar BD, Anti DNA antibodies. Clin Immunol Allergy 1981; 1: 24359.
  • 51
    Pisetsky DS. Antinuclear antibodies. Diagn Lab Immunol 1994; 14: 37185.
  • 52
    Swaak T, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody. Ann Rheum Dis 1985; 44: 24551.
  • 53
    Isenberg D, Shoenfeld Y. The origin and significance of anti-DNA antibodies. Immunol Today 1987; 8: 27981.
  • 54
    Tan EM. Autoantibody to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 1982; 33: 167240.
  • 55
    Pollard KM, Jones JE, Tan EM, Theofilopoulos AN, Dixon FJ, Rubin RL. Polynucleotide specificity of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol 1986; 40: 197208.
  • 56
    Tasneem S, Ali R. Antigenicity of poly(I) and ROS-poly(I) and their recognition of human anti-DNA autoantibodies. Immunol Invest 2001; 30: 33545.
  • 57
    Arif Z, Ali R. Antigenicity of poly(dA-dT) poly(dA-dT) photo-crosslinked with 8-methoxypsoralen. Arch Biochem Biophys 1996; 329: 1918.
  • 58
    Ahmad J, Ashok BT, Ali R. Reactive oxygen species modified thymine and poly(dT) represent unique epitope for human anti-DNA autoantibodies. Immunol Lett 1997; 58: 6974.
  • 59
    Stollar BD. Immunochemistry of DNA. Int Rev Immunol 1989; 5: 122.
  • 60
    Blount S, Griffiths HR, Lunec J. Reactive oxygen species induce antigenic changes in DNA. FEBS Lett 1989; 245: 1004.
  • 61
    Ahmad R, Alam K, Ali R. Antigen binding characteristics of antibodies against hydroxyl radical modified thymidine monophosphate. Immunol Lett 2000; 71: 1115.
  • 62
    Ashok BT, Ali R. Antigen binding characteristics of experimentally-induced antibodies against hydroxyl radical modified native DNA. Autoimmunity 1999; 29: 119.
  • 63
    Ashok BT, Ahmad J, Qadri A, Ali R. Anti-ROS-DNA monoclonal antibody as molecular probe for DNA damage. Biochem Mol Biol Int 1997; 43: 121929.
  • 64
    Blount S, Griffiths HR, Lunec J. Reactive oxygen species damage to DNA and its role in systemic lupus erythematosus. Mol Asp Med 1991; 12: 93105.
  • 65
    Blount S, Griffiths HR, Lunec J. Reactive oxygen species modified human DNA eliciting a more discriminating antigen for the diagnosis of systemic lupus erythematosus. Clin Exp Immunol 1990; 81: 3849.
  • 66
    Ahmad J, Ashok BT, Ali R. Detection of oxidative DNA damage by a monoclonal antibody: role of lysyl residues in antigen binding. Immunol Lett 1998; 62: 8792.
  • 67
    Ashok BT, Ali R. Binding of circulating antibodies to reactive oxygen species modified-DNA and detecting DNA damage by a monoclonal antibody probe. Mech Ageing Dev 1998; 103: 6980.
  • 68
    Wu DP, Gilkeson GS, Armitage J, Reich CE, Pisetsky DS. Selective recognition of DNA antigenic determinants by murine monoclonal anti-DNA antibodies. Clin Exp Immunol 1990; 82: 337.
  • 69
    Hardin JA. The lupus autoantigens and the pathogenesis of SE. Arth Rheum 1986; 29: 45761.
  • 70
    Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995; 144: 15793.
  • 71
    Linker-Israeli M, Quismorio FP, Horwitz DA. CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. Arth Rheum 1990; 33: 121625.
  • 72
    Mignotte B, Vayssiere J-L. Mitochondria and apoptosis. Eur J Biochem 1998; 252: 115.
  • 73
    Lorenz H-M, Herrmann M, Kalden JM. The pathogenesis of autoimmune diseases. Scand J Clin Laboratory Invest 2001; 61 (Suppl. 235):1626.
  • 74
    Bijl M, Limburg PC, Kallenberg CGM. New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis. Neth J Med 2001; 59: 6675.
  • 75
    Courtney PA, Crockard AD, Williamson K et al. Increased peripheral blood neutrophils in systemic lupus erythematosus. relations with disease activity, antibodies to double stranded DNA and neutropenia. Ann Rheum Dis 1999; 58: 124150.
  • 76
    Bijl M, VanLopik T, Limburg PC. Do elevated levels of serum soluble fas contribute to the persistance of activated lymphocytes in systemic lupus erythematosus? J Autoimmunity 1998; 11: 45763.
  • 77
    Gordon C, Salmon M. Update on systemic lupus erythematosus: autoantibodies and apoptosis. Clin Med 2001; 1: 104.
  • 78
    Funauchi M, Sugiyama M, Sukyoo B, Ikoma S, Ohno M, Kinoshita K, Kanamaru A. A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus. Lupus 2001; 10: 2848.
  • 79
    Hermann M, Voll RE, Zopller OM et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophage from patients with systemic lupus erythematosus. Arth Rheum 1998; 41: 124150.
  • 80
    Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease. A problem of defective apoptosis. Arth Rheum 1994; 37: 141520.
  • 81
    Emlen W, Neibur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 368592.
  • 82
    Casiano CA, Tan EM. Recent developments in the understanding of antinuclear antibodies. Int Arch Allergy Immunol 1996; 114: 30813.
  • 83
    Cabral AR, Alarcon-Segovia D. Autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 1997; 9: 38792.
  • 84
    Vaishnaw AK, McNally JD, Elkon KB. Apoptosis in rheumatic diseases. Arth Rheum 1997; 40: 191727.
  • 85
    Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 1990; 86: 6974.
  • 86
    Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177: 136781.
  • 87
    Gilbert D, Brard F, Jovelin F, Tron F. Do naturally occurring autoantibodies participate in the constitution of the pathological B-cell repertoire in systemic lupus erythematosus? J Autoimmunity 1996; 9: 24757.
  • 88
    Morioka T, Fujigaki Y, Batsford SR et al. Anti-DNA antibody derived from a systemic lupus erythematosus patient forms histone-DNA-anti-DNA complexes that bind to rat glomeruli in vivo. Clin Exp Immunol 1996; 104: 926.
  • 89
    Gruschwitz MS, Shoenfeld Y, Krupp M et al. Antinuclear antibody profile in UCD line 200 chickens: a model for progressive systemic sclerosis. Int Arch Allergy Immunol 1993; 100: 30713.
  • 90
    Reimer G, Scheer U, Peters JM, Tan EM. Immunolocalization and partial characterization of a nucleolar antigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. J Immunol 1986; 137: 38028.
  • 91
    Garg DK, Ali R. Reactive oxygen species modified polyguanylic acid: immunogenicity and implications for systemic autoimmunity. J Autoimmunity 1998; 11: 3718.
  • 92
    Schorer AE, Wickham NW, Watson KV. Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial pro-stacyclin release and platelet aggregation. Br J Haematol 1989; 71: 399407.
  • 93
    Zouali M. The structure of human lupus anti-DNA antibodies. Methods 1997; 11: 2735.
  • 94
    Klinman DM, Steinberg AD. Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 1987; 165: 175560.
  • 95
    Bloom DD, Davignon JL, Cohen PL, Eisenberg RA, Clarke SH. Overlap of the anti-Sm and anti-DNA responses of MRL/MP-lpr/lpr mice. J Immunol 1993; 150: 157990.
  • 96
    Radic MZ, Mascelli MA, Erikson J, Shan H, Weigert M. Ig H and L chain contributions to autoimmune specificities. J Immunol 1991; 146: 17682.
  • 97
    Zouali M, Druilhe P, Gentilini M, Eyquem A. High titres of anti-T antibodies and other haemagglutins in human malaria. Clin Exp Immunol 1982; 50: 8391.
  • 98
    Fredriksen K, Osei A, Sundsfjord A, Traavik T, Rekvig OP. On the origin of anti-double stranded (ds) DNA antibodies: systemic lupus erythematosus related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZW × NZW) F1 hybrids, but not in normal mice. Eur J Immunol 1994; 24: 6670.